Options for radionuclide therapy: from fixed activity to patient-specific treatment planning.

@article{Thomas2002OptionsFR,
  title={Options for radionuclide therapy: from fixed activity to patient-specific treatment planning.},
  author={Stephen R. Thomas},
  journal={Cancer biotherapy & radiopharmaceuticals},
  year={2002},
  volume={17 1},
  pages={
          71-82
        }
}
The therapeutic use of radioisotopes in medicine as unsealed sources has a long history dating back to the 1930s. The established and continuing objectives are to provide radiation dose to the target tissue at the desired cytotoxic level while avoiding or minimizing toxic effects. Selected radionuclide therapy protocols including 32P for polycythemia vera, 131I for Graves' disease, and 131I for postsurgical ablation of thyroid remnants in the management of differentiated thyroid cancer are… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 52 REFERENCES

Introduction

EE Furhang, CS Chui, G Sgouros
  • Sem Rad Onc
  • 2000

Radioiodine uptake in thyroid remnants during therapy after tracer dosimetry.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2000

a.) The invention of radioiodine treatment of hyperthyroidism: Part 1

CT Sawin, DV Becker
  • Thyroid Today XXIII: 1-11,
  • 2000

Radionuclide therapy

Chatal J-F, CA Hoefnagel
  • Lancet
  • 1999